Neurizon Therapeutics Limited (ASX:NUZ)
Australia · Delayed Price · Currency is AUD 0.0870
+0.0020 (2.35%)
Apr 20, 2026, 2:26 PM AEST
Neurizon Therapeutics Market Cap
Neurizon Therapeutics has a market cap or net worth of 61.67 million as of April 20, 2026. Its market cap has decreased by -3.64% in one year.
Market Cap
61.67M
Enterprise Value
55.35M
Revenue
5.98M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
Market Cap Chart
Since September 12, 2002, Neurizon Therapeutics's market cap has increased from 4.18M to 61.67M, an increase of 1,374.29%. That is a compound annual growth rate of 12.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 61.67M | 35.42% |
| Dec 31, 2025 | 45.54M | -45.58% |
| Dec 31, 2024 | 83.69M | 94.55% |
| Dec 29, 2023 | 43.02M | 112.09% |
| Dec 30, 2022 | 20.28M | -36.00% |
| Dec 31, 2021 | 31.69M | -4.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Botanix Pharmaceuticals | 97.57M |
| Cynata Therapeutics | 85.48M |
| Amplia Therapeutics | 84.66M |
| LTR Pharma | 72.71M |
| Radiopharm Theranostics | 72.66M |
| Prescient Therapeutics | 53.63M |
| Imugene | 53.55M |
| Proteomics International Laboratories | 45.43M |